Administration of 1200 mg/day of ALA in a small group of lean PCOS women led to a significant improvement in insulin sensitivity: this indicated a possible favorable effect on the patients’ menstrual cycles, without, however, achieving any change in body weight. Here, INS is linked to polycystic ovary syndrome.